Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrique Ocio

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Hematology (Amsterdam, Netherlands)|April 18, 2012
Multiple myeloma: treatment evolutionJesus F San Miguel, Maria Victoria Mateos, Enrique Ocio, et al.
Frontiers in Immunology|May 13, 2024
Brave new world: expanding home care in stem cell transplantation and advanced therapies with new technologiesIñigo Romon, Soledad Gonzalez-Barrera, Carmen Coello de Portugal, et al.
Haematologica|May 10, 2007
Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significancePatricia Martín-Jiménez, Ramón García-Sanz, Ana Balanzategui, et al.
British Journal of Haematology|November 14, 2006
Functional class switch recombination may occur 'in vivo' in Waldenström macroglobulinaemiaPatricia Martín-Jiménez, Ramón García-Sanz, María E Sarasquete, et al.
Transfusion|May 6, 2024
Adverse effects of therapeutic phlebotomies: Prospective study of 587 proceduresIñigo Romón, Juan Domíguez-García, Carlos Fernández, et al.
BMC Geriatrics|October 19, 2021
Convalescent plasma treatment for patients of 80 years and older with COVID-19 pneumoniaIñigo Romon, Juan J Dominguez-Garcia, Jose L Arroyo, et al.
Haematologica|July 22, 2008
The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytesSoraya Tabera, José A Pérez-Simón, María Díez-Campelo, et al.
Haematologica|February 22, 2024
Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myelomaMaria Victoria Mateos, Katja Weisel, Evangelos Terpos, et al.
British Journal of Haematology|August 30, 2002
Methylation is an inactivating mechanism of the p16 gene in multiple myeloma associated with high plasma cell proliferation and short survivalMaria V Mateos, Ramón García-Sanz, Ricardo López-Pérez, et al.
British Journal of Haematology|September 1, 2007
Inhibition of Akt induces significant downregulation of survivin and cytotoxicity in human multiple myeloma cellsTeru Hideshima, Laurence Catley, Noopur Raje, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Hematology (Amsterdam, Netherlands)|April 18, 2012
Multiple myeloma: treatment evolutionJesus F San Miguel, Maria Victoria Mateos, Enrique Ocio, et al.
Frontiers in Immunology|May 13, 2024
Brave new world: expanding home care in stem cell transplantation and advanced therapies with new technologiesIñigo Romon, Soledad Gonzalez-Barrera, Carmen Coello de Portugal, et al.
Haematologica|May 10, 2007
Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significancePatricia Martín-Jiménez, Ramón García-Sanz, Ana Balanzategui, et al.
British Journal of Haematology|November 14, 2006
Functional class switch recombination may occur 'in vivo' in Waldenström macroglobulinaemiaPatricia Martín-Jiménez, Ramón García-Sanz, María E Sarasquete, et al.
Transfusion|May 6, 2024
Adverse effects of therapeutic phlebotomies: Prospective study of 587 proceduresIñigo Romón, Juan Domíguez-García, Carlos Fernández, et al.
BMC Geriatrics|October 19, 2021
Convalescent plasma treatment for patients of 80 years and older with COVID-19 pneumoniaIñigo Romon, Juan J Dominguez-Garcia, Jose L Arroyo, et al.
Haematologica|July 22, 2008
The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytesSoraya Tabera, José A Pérez-Simón, María Díez-Campelo, et al.
Haematologica|February 22, 2024
Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myelomaMaria Victoria Mateos, Katja Weisel, Evangelos Terpos, et al.
British Journal of Haematology|August 30, 2002
Methylation is an inactivating mechanism of the p16 gene in multiple myeloma associated with high plasma cell proliferation and short survivalMaria V Mateos, Ramón García-Sanz, Ricardo López-Pérez, et al.
British Journal of Haematology|September 1, 2007
Inhibition of Akt induces significant downregulation of survivin and cytotoxicity in human multiple myeloma cellsTeru Hideshima, Laurence Catley, Noopur Raje, et al.
Pageof 2